Single vs Serial Measurements of Cardiac Troponin Level in the Evaluation of Patients in the Emergency Department With Suspected Acute Myocardial Infarction

Abstract

IMPORTANCE Chest pain is among the most common reasons for emergency department (ED) presentations. However, most patients are at low risk for acute coronary syndrome (ACS), with low cardiac adverse outcomes rates. Biomarker testing with troponin levels is key in the initial assessment for ACS. Although serial troponin testing can improve the diagnosis of ACS in clinical practice, some patients deemed to be low risk are discharged after a single negative troponin test result.OBJECTIVE To report the clinical outcomes of patients discharged after a single negative troponin test result compared with patients discharged after serial troponin measurements. DESIGN, SETTING, AND PARTICIPANTSThis is a retrospective cohort study of ED encounters from May 5, 2016, to December 1, 2017, across 15 community EDs within an integrated health care system in southern California. The study cohort includes 27 918 adult ED encounters in which patients were evaluated for suspected ACS with a HEART (history, electrocardiogram, age, risk factors, and troponin) score and an initial conventional troponin-I measurement below the level of detection (<0.02 ng/mL). Statistical analysis was performed from December 1, 2019, to December 1, 2020. EXPOSURE Single troponin test vs multiple troponin tests. MAIN OUTCOMES AND MEASURES The primary outcome was acute myocardial infarction or cardiac mortality; secondary outcomes included coronary artery bypass graft, percutaneous coronary intervention, invasive coronary angiography, and unstable angina within 30 days of discharge. A multivariable logistic regression model was performed to evaluate the association between testing strategies and clinical outcomes. RESULTS A total of 27 918 patient encounters (16 212 women [58.1%]; mean [SD] age, 58.7 [15.2] years) were included in the study. Of patients with an initial troponin measurement below the level of detection, 14 459 (51.8%) were discharged after a single troponin measurement, and 13 459 (48.2%) underwent serial troponin tests. After adjustment for cardiac risk factors and comorbidities, there was no statistically significant difference in the primary outcome of acute myocardial infarction or cardiac mortality within 30 days between the 2 groups (single troponin, 56 [0.4%] vs serial troponin, 52 [0.4%]; adjusted odds ratio, 1.41 [95% CI, 0.96-2.07]). Patients discharged after a single troponin test had lower rates of coronary artery bypass graft (adjusted odds ratio, 0.24 [95% CI, 0.11-0.48]) and invasive coronary angiography (adjusted odds ratio, 0.46 [95% CI, 0.38-0.56]). (continued) Key Points Question Do patients discharged from the emergency department after a single troponin test with negative results have similar outcomes to patients undergoing multiple troponin tests? Findings This cohort study found no significant difference in 30-day acute myocardial infarction or cardiac mortality between patients receiving a single troponin test with negative results and those who underwent serial troponin tests (single troponin test, 0.4% vs serial tr...

Referral decisions based on a pre-hospital HEART score in suspected non-ST-elevation acute coronary syndrome: final results of the FamouS Triage study

“…Apart from that, new insights are emerging that single troponin tests instead of serial testing in managing patients suspected for NSTE-ACS appears to be safe and is a reasonable strategy to possibly improve efficiency without an adverse association with patient outcomes. 36 …”

Biomarker und Histologie bei idiopathischen inflammatorischen Myopathien

“…Troponine gelten als myokardspezifisch und spielen deshalb eher im Rahmen der kardialen Diagnostik, insbesondere im Bereich des akuten Koronarysyndroms eine wesentliche Rolle [12]. Im Kontext der IIM werden Troponine oft zum Nachweis bzw.…”

Effects of nicorandil on systemic inflammation and oxidative stress induced by percutaneous coronary intervention in patients with coronary heart disease

“…Compared with the effects of traditional drug therapy, PCI can more effectively improve coronary blood flow, restore myocardial perfusion, reduce myocardial ischemia or the infarction area, and improve clinical prognoses. 1 , 2 However, some patients with AMI or UA do not benefit from PCI because of myocardial no-reflow (MNR). 3 …”

“…Compared with the effects of traditional drug therapy, PCI can more effectively improve coronary blood flow, restore myocardial perfusion, reduce myocardial ischemia or the infarction area, and improve clinical prognoses. 1,2 However, some patients with AMI or UA do not benefit from PCI because of myocardial no-reflow (MNR). 3 The absence of MNR, which is also called coronary stent reflux, is considered a manifestation of coronary function disorders during the reperfusion of acute myocardial ischemia.…”